Castleview Partners, LLC Corcept Therapeutics Inc Transaction History
Castleview Partners, LLC
- $151 Million
- Q4 2024
A detailed history of Castleview Partners, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Castleview Partners, LLC holds 865 shares of CORT stock, worth $51,060. This represents 0.03% of its overall portfolio holdings.
Number of Shares
865Holding current value
$51,060% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding CORT
# of Institutions
349Shares Held
86.1MCall Options Held
1.12MPut Options Held
667K-
Black Rock Inc. New York, NY16.5MShares$976 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$591 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.27MShares$488 Million14.93% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.51MShares$384 Million0.48% of portfolio
-
Parallel Advisors, LLC3.81MShares$225 Million4.22% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $6.32B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...